Ligand Pharmaceuticals (LGND)
(Real Time Quote from BATS)
$81.52 USD
-0.85 (-1.03%)
Updated Jun 7, 2024 01:30 PM ET
2-Buy of 5 2
C Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Ligand Pharmaceuticals Incorporated [LGND]
Reports for Purchase
Showing records 701 - 717 ( 717 total )
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
EMA to Review Regulatory Submission for Partner Pfizer''s Bazedoxifene
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Biotech Royalty; Initiating Coverage with Buy
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of June 17This report contains brief updates on the following: PCYC, LGND, ONXX, RGEN, ANAC, ARNA, ONCY, CRDC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
C. K. COOPER HEALTHCARE DROPPING COVERAGE
Provider: C.K. Cooper and Company
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a BUY rating and a 12-month price target of $18.
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
HEALTHCARE -- SUSPENDING COVERAGE : Due to analyst departure.
Provider: C.K. Cooper and Company
Analyst: COHEN J
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Company: Ligand Pharmaceuticals Incorporated
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.